20 research outputs found
Discrimination between CO and O<sub>2</sub> in Heme Oxygenase: Comparison of Static Structures and Dynamic Conformation Changes following CO Photolysis
Heme oxygenase (HO) catalyzes heme degradation, one of
its products
being carbon monoxide (CO). It is well known that CO has a higher
affinity for heme iron than does molecular oxygen (O<sub>2</sub>);
therefore, CO is potentially toxic. Because O<sub>2</sub> is required
for the HO reaction, HO must discriminate effectively between CO and
O<sub>2</sub> and thus escape product inhibition. Previously, we demonstrated
large conformational changes in the heme–HO-1 complex upon
CO binding that arise from steric hindrance between CO bound to the
heme iron and Gly-139. However, we have not yet identified those changes
that are specific to CO binding and do not occur upon O<sub>2</sub> binding. Here we determine the crystal structure of the O<sub>2</sub>-bound form at 1.8 Å resolution and reveal the structural changes
that are specific to CO binding. Moreover, difference Fourier maps
comparing the structures before and after CO photolysis at <160
K clearly show structural changes such as movement of the distal F-helix
upon CO photolysis. No such changes are observed upon O<sub>2</sub> photolysis, consistent with the structures of the ligand-free, O<sub>2</sub>-bound, and CO-bound forms. Protein motions even at cryogenic
temperatures imply that the CO-bound heme–HO-1 complex is severely
constrained (as in ligand binding to the T-state of hemoglobin), indicating
that CO binding to the heme–HO-1 complex is specifically inhibited
by steric hindrance. The difference Fourier maps also suggest new
routes for CO migration
Alternative cyanide-binding modes to the haem iron in haem oxygenase
Alternative cyanide-binding modes in the haem–haem oxygenase complex are described
A microfluidic-based protein crystallization method in 10 micrometer-sized crystallization space
Protein crystallization and subsequent X-ray diffraction analysis of the three-dimensional structure are necessary for elucidation of the biological functions of proteins and effective rational drug design. Therefore, controlling protein crystallization is important to obtain high resolution X-ray diffraction data. Here, a simple microfluidic method using chips with 10 and 50 μm high crystallization chambers to selectively form suitable single protein crystals for X-ray analysis is demonstrated. As proof of concept, three different types of proteins: lysozyme, glucokinase from Pseudoalteromonas sp. AS-131 (PsGK), and NADPH-cytochrome P450 oxidoreductase–heme oxygenase complex were crystallized. We demonstrate that the crystal growth orientation depends on the height of the crystallization chamber regardless of the protein type. Our results suggest that the confined micro space induces the protein molecules to adhere to a specific crystal face and affects the growth kinetics of each crystal face. The present microfluidic-based protein crystallization method can reform a suitable single protein crystal for X-ray analysis from aggregates of needle-shaped protein crystals
Distal Regulation of Heme Binding of Heme Oxygenase‑1 Mediated by Conformational Fluctuations
Heme
oxygenase-1 (HO-1) is an enzyme that catalyzes the oxidative
degradation of heme. Since free heme is toxic to cells, rapid degradation
of heme is important for maintaining cellular health. There have been
useful mechanistic studies of the HO reaction based on crystal structures;
however, how HO-1 recognizes heme is not completely understood because
the crystal structure of heme-free rat HO-1 lacks electron densities
for A-helix that ligates heme. In this study, we characterized conformational
dynamics of HO-1 using NMR to elucidate the mechanism by which HO-1
recognizes heme. NMR relaxation experiments showed that the heme-binding
site in heme-free HO-1 fluctuates in concert with a surface-exposed
loop and transiently forms a partially unfolded structure. Because
the fluctuating loop is located over 17 Å distal from the heme-binding
site and its conformation is nearly identical among different crystal
structures including catalytic intermediate states, the function of
the loop has been unexamined. In the course of elucidating its function,
we found interesting mutations in this loop that altered activity
but caused little change to the conformation. The Phe79Ala mutation
in the loop changed the conformational dynamics of the heme-binding
site. Furthermore, the heme binding kinetics of the mutant was slower
than that of the wild type. Hence, we concluded that the distal loop
is involved in the regulation of the conformational change for heme
binding through the conformational fluctuations. Similar to other
enzymes, HO-1 effectively promotes its function using the identified
distal sites, which might be potential targets for protein engineering